Active surveillance versus treatment in low-risk DCIS: Women’s preferences in the LORD-trial

BACKGROUND: Ductal carcinoma in situ (DCIS) can progress to invasive breast cancer (IBC), but most DCIS lesions remain indolent. However, guidelines recommend surgery, often supplemented by radiotherapy. This implies overtreatment of indolent DCIS. The non-randomised patient preference LORD-trial te...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmitz, Renée S.J.M., Engelhardt, Ellen G., Gerritsma, Miranda A., Sondermeijer, Carine M.T., Verschuur, Ellen, Houtzager, Julia, Griffioen, Rosalie, Retèl, Valesca, Bijker, Nina, Mann, Ritse M., van Duijnhoven, Frederieke, Wesseling, Jelle, Bleiker, Eveline M.A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632767/
https://www.ncbi.nlm.nih.gov/pubmed/37657228
http://dx.doi.org/10.1016/j.ejca.2023.113276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632767/
https://www.ncbi.nlm.nih.gov/pubmed/37657228
http://dx.doi.org/10.1016/j.ejca.2023.113276

Ejemplares similares